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Abstract
Background: The statistical study of biological networks has led to important novel biological insights, such as the
presence of hubs and hierarchical modularity. There is also a growing interest in studying the statistical properties
of networks in the context of cancer genomics. However, relatively little is known as to what network features
differ between the cancer and normal cell physiologies, or between different cancer cell phenotypes.
Results: Based on the observation that frequent genomic alterations underlie a more aggressive cancer
phenotype, we asked if such an effect could be detectable as an increase in the randomness of local gene
expression patterns. Using a breast cancer gene expression data set and a model network of protein interactions
we derive constrained weighted networks defined by a stochastic information flux matrix reflecting expression
correlations between interacting proteins. Based on this stochastic matrix we propose and compute an entropy
measure that quantifies the degree of randomness in the local pattern of information flux around single genes. By
comparing the local entropies in the non-metastatic versus metastatic breast cancer networks, we here show that
breast cancers that metastasize are characterised by a small yet significant increase in the degree of randomness of
local expression patterns. We validate this result in three additional breast cancer expression data sets and
demonstrate that local entropy better characterises the metastatic phenotype than other non-entropy based
measures. We show that increases in entropy can be used to identify genes and signalling pathways implicated in
breast cancer metastasis and provide examples of de-novo discoveries of gene modules with known roles in
apoptosis, immune-mediated tumour suppression, cell-cycle and tumour invasion. Importantly, we also identify a
novel gene module within the insulin growth factor signalling pathway, alteration of which may predispose the
tumour to metastasize.
Conclusions: These results demonstrate that a metastatic cancer phenotype is characterised by an increase in the
randomness of the local information flux patterns. Measures of local randomness in integrated protein interaction
mRNA expression networks may therefore be useful for identifying genes and signalling pathways disrupted in one
phenotype relative to another. Further exploration of the statistical properties of such integrated cancer expression
and protein interaction networks will be a fruitful endeavour.
Background
The statistical study of biological networks has shed
substantial novel insights into how biological networks
are organised and how this organisation may relate to
cellular function [1]. An important class of biological
networks are protein interaction networks (PINs), as
determined from high-throughput interaction screens
and literature curation [2-4]. Edges in these networks
mainly describe interactions of proteins that are part of
the same physical complex or posttranslational modifi-
cations mediating signal transduction flows. Topological
studies of these PINs have shown that they have impor-
tant properties such as scale-freeness of the degree dis-
tribution, characterised by most proteins having small
degree constrasting with a small yet significant number
of highly connected nodes, called hubs [1]. Hubs have
been shown to encode for essential genes in the context
of yeast knock-out experiments [5] and are also fre-
quently altered in cancer [6,7], highlighting that topolo-
gical properties of these networks may carry important
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biological information. More recently, hierarchical mod-
ularity and betweenness centrality are other network
properties that have been actively investigated in the
context of biological networks [8,9]. Specifically, the
observation that proteins of high betweenness centrality
tend to be also essential [9] and may also be frequently
altered in cancer [10,11] suggests that proteins of high
betweenness centrality are also important for normal
cellular physiology. However, it is recognised that well-
known disease genes are more frequently studied lead-
ing to literature bias and hence to a skew in the
topological properties of such genes [12].
Existing PINs are also largely incomplete and there-
fore only represent very crude models of protein inter-
actions [2]. Nevertheless they have provided useful
structural models and their integration with gene
expression data has led to novel insights, also in cancer
genomics where they have helped identify candidate
gene modules driving disease progression and novel
diagnostic/prognostic markers [11,13]. A distinct advan-
tage of the integrative PIN-mRNA expression approach
is that it can overcome some of the inherent problems
associated with analysing gene expression data on its
own, such as poor signal to noise ratios and the diffi-
culty of interpreting gene expression signatures. Indeed,
integrative PIN-mRNA expression studies have helped
tease out relevant patterns of expression variation in the
contextual framework of signalling pathways and protein
complexes [14,15]. Another potential advantage of using
PINs is in relation to expression correlation networks to
distinguish between direct and indirect correlations. For
example, partial correlations and Graphical Gaussian
Models have been proposed for deriving relevance net-
works where edges represent only potential direct influ-
ences between genes [16]. An alternative to partial
correlations is to use the structural PIN to remove the
(long-distance) indirect correlations between genes.
So far though the focus has been on the identification
of specific subnetworks that may be causally involved in
disease progression [11,13,17-19]. Much less has been
done on the exploration of statistical properties of net-
works underlying the cancer phenotype with the excep-
tion of [12] where they performed a comprehensive
analysis of cancer networks by first selecting genes dif-
ferentially expressed between cancer and normal tissue
(the “seeds”) and then constructing the networks as the
nearest-neighbor PIN expansion of these seeds. It has
become clear however that using PIN information a
posteriori does not make full justice of the potential
offered by a genuine integrative PIN-mRNA expression
analysis. Indeed, it is increasingly recognised that
approaches based on single-gene differential expression
analysis are too simplistic and have been gradually
superseeded by network-based methods [11,13]. A
deeper understanding of the statistical properties of the
underlying cancer networks is therefore important, as
this may guide the choice of network metrics to use for
better identifying signalling pathways or functional mod-
ules involved in disease progression.
In this work we investigate statistical properties [20] of
integrated PIN-mRNA expression networks with the aim
of identifying network properties that vary significantly
between different cancer phenotypes. In particular, we
hypothesized that since the frequency of genomic altera-
tions is generally associated with a poor prognosis phe-
notype [21,22], that this could be reflected by
disruptions in the integrated PIN-mRNA expression net-
works, which would manifest as increases in the ran-
domness of the local correlation patterns. To this end,
we here introduce a local entropy measure that quanti-
fies such randomness and demonstrate that (i) entropy
is increased in primary tumours that metastasize (hence-
forth “metastatic phenotype”), (ii) that it better charac-
terises the metastatic phenotype than other metrics
which do not quantify randomness, and (iii) that this
entropy measure can be used to discover genes and
associated functional modules involved in cancer pro-
gression. To our knowledge this constitutes the first
demonstration that metastatic cancer is characterised by
a higher degree of randomness in the underlying signal
transduction patterns and that this effect can be mea-
sured from integration of gene expression data with
existing PINs.
Methods
The protein interaction network
We downloaded the Human Protein Reference Database
(HPRD) interaction network [2] from Pathway Com-
mons http://www.pathwaycommons.org The HPRD net-
work has been manually extracted from the literature by
expert biologists who read, interpret and analyze the
published data. Protein interactions in this network
include physical stable interactions such as those defin-
ing protein complexes, as well as transient interactions
such as post-translational modifications and enzyme
reactions found in signal-transduction pathways, includ-
ing 20 highly curated immune and cancer signalling
pathways ("NetPath”). The HPRD network used here
consisted of 8396 proteins with 36877 documented
interactions.
Breast cancer gene expression data sets
We downloaded the normalised data of four breast can-
cer gene expression data sets from GEO http://www.
ncbi.nlm.nih.gov/geo/[23-26]. These data sets were all
profiled with the Affymetrix platform. We refer to these
data sets as “EMC” (Erasmus Medical Centre) [23],
“Frid” [24], “LoiUnt” [25] and “Mainz” [26]. In the case
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of [25] we used the data from the untreated patient
population. As clinical endpoint we used a binary out-
come variable indicating if the tumour metastasized or
not. This was possible for the Mainz, Frid and LoiUnt
data sets. For the EMC cohort, we used recurrence as a
surrogate. The number of samples and their breakup
according to clinical outcome in each study were 286
(107 recurred, 179 no recurrence) for “EMC”, 200 (46
metastasized, 154 no metastasis) for “Mainz”, 129
(27 metastasized, 102 no metastasis) for “Frid” and 125
(28 metastasized, 97 no metastasis) for “LoiUnt”. To
simplify the jargon we also refer to samples that
recurred (EMC cohort) as metastatic samples.
Integrated PIN-mRNA expression networks
Next, we built integrated PIN-mRNA expression net-
works from the HPRD PIN and a gene expression data
matrix. From the PIN we first extracted the proteins for
which there were corresponding gene expression pro-
files. Typically, this resulted in a reduced PIN over
approximately 7000 common genes/proteins with a 1-1
correspondence between nodes in the PIN and gene
expression profiles. The reduced PIN had several con-
nected components, the maximally connected compo-
nent containing approximately 95% of the original
nodes. Let Pij denote the adjacency matrix of the PIN
and let N denote the number of nodes.
Since we are interested in investigating differences
in network properties between metastatic and non-
metastatic cancer we constructed correlation expression
networks by separately computing gene pairwise Pearson
correlations across metastatic and non-metastatic can-
cers. Since typically the number of metastatic samples is
less than that of non-metastatic tumours, to ensure that
results are independent of system-size, we subselected a
number of non-metastatic tumours at random from the
original set. Thus, let Cij
M( ) denote the Pearson correla-
tion of genes i and j across the nM metastatic samples,
and let Cij
N( ) denote the corresponding correlation
across nM randomly selected non-metastatic samples.
We then assign to each pair of genes an edge weight
wij = Cij. Finally, since we are interested in the patterns
of local correlation we set wij = 0 whenever Pij = 0.
Thus, we assign nonzero weights only to edges that are
present in the corresponding PIN. The resulting net-
work defines the integrated PIN-mRNA network, and
while the structural networks are identical for the meta-
static and non-metastic phenotypes, the values of the
edge weights will differ.
The stochastic information flux matrix
There is still freedom in how we can assign weights to
the edges in the PIN-mRNA network. In particular,
since -1 ≤ Cij ≤ 1, we may redefine the edge weights as
C w Cij ij ij→ ≡ +( )12 1 for both the metastatic andnon-metastatic correlation networks. This monotonic
transformation ensures that the edge weights satisfy 0 ≤
wij ≤ 1. A weight close to 1 represents therefore a strong
positive correlation between the two genes, a weight of
approximately 0.5 describes a non-existent correlation,
while strong negative correlations will be assigned small
weights. For any given node i with neighbours j Î N(i)
where N(i) = {j Î N: Pij = 1}, we can then assign a prob-
ability distribution as follows:
p
w
w
ij
ij
j N i ij
=
∈ ( )∑ (1)
so that ∑jÎN(i)pij = 1. We note that while this defines a
stochastic matrix, it is not doubly stochastic, i.e ∑iÎN(j)pij
≠ 1, because in general pij ≠ pji.
We interpret this probability distribution as follows.
Strong positive correlations in the PIN very likely
describe interactions that are necessary for the cell to
carry out a specific modular function. We call this a
“positive information flux” interaction to indicate that
this interaction describes propagation of an activating
signal. Thus, although the positive interaction could be
between members of a given complex without explicitly
representing signal transduction flow, we nevertheless
argue that the positive correlation is necessary for the
protein complex to carry out a specific function within
the (signal transduction) pathway in which it operates.
Because of this, we interpret negative correlations as
“negative information flux” interactions to indicate that
complexes may be in an inactive state or to represent
inhibitory interactions. Thus, these interactions are
given the smallest “positive flux” weights. Weak or near-
zero correlations are given a larger positive flux (pij ~
0.5) than negative interactions (pij ~ 0) because we
argue that these interactions have less evidence for
inducing an inactivating signal. Thus, the integrated
PIN-mRNA networks with the edge weights defined by
pij as in equation (1) describe positive flux interactions
(as measured by gene-gene correlations in expression)
subject to the structural constraint of the PIN. Applying
this procedure to the two C(M) and C(N) correlation
matrices, yields two integrated PIN-mRNA networks,
one for the metastatic phenotype with stochastic matrix
Pij
M( ) , and one for the non-metastatic phenotype with
stochastic matrix Pij
N( ) Since the number of metastatic
samples is less than that of non-metastatic tumours
(true for all cohorts considered here), and since we con-
structed the weighted networks using the same number
of samples from each phenotype, we have freedom in
the choice of non-metastatic samples to use. We exploit
this freedom by making in each cohort 10 random
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selections of non-metastatic samples (in each case
selecting the same number of samples as there are of
metastatic cases), called “bootstraps”, which allows the
robustness of our results to be evaluated.
We point out that gene expression gives only a rough
proxy for protein activity and that therefore our inte-
grated PIN-mRNA networks and stochastic information
flux matrices only represent very crude models of signal
transduction flow. In particular, we expect many egdes
to be assigned low fluxes when in fact corresponding
protein levels and activities may be highly correlated.
Thus, it is clear that our networks do not represent
truly integrated networks. However, in the absence of
large-scale protein expression and phosphorylation data,
specially in relation to cancer phenotypes, relying on
correlations in mRNA expression between genes whose
protein products have been documented to physically
interact (including postranslational modifications) is one
viable alternative.
Entropy of information flux distribution
We propose the following entropy measure [20] that
quantifies the amount of randomness/disorder in the
local flux distribution surrounding any given node i Î
N. This measure is similar to the local disparity/hetero-
geneity index of weighted networks considered in other
contexts [27,28]. Specifically, if ki denotes the degree of
node i, then the local entropy of node i is defined by
S
k
p pi
i
ij
j N i
ij= −
∈
∑1log log
( )
(2)
Thus, in the extreme case where all the flux is con-
strained along one interaction, pij = δij (where δij is the
Kronecker-delta), Si = 0, while in the case where the
flux is distributed equally across all edges i.e if pij = 1/ki,
the entropy attains its maximum value Si = 1.
We denote by S the distribution of local entropies
across the whole network, i.e S = {S1,..., SN} where N is
the number of nodes in the network. Since the stochas-
tic matrix pij is defined separately for metastatic and
non-metastatic phenotypes we obtain separate distribu-
tions of local entropies S(M) and S(N).
To determine if these two distributions are signifi-
cantly different we use the non-parametric paired Wil-
coxon rank sum test. The paired test is appropriate
because we need to control for possible dependencies
between the two entropy values associated with each
node (see below). We use the P-value of the test as a
measure of the degree of difference between the values
in the two phenotypes. We also define a differential
entropy, dS (also denoted as “diffS”), on a node-by-node
basis, by
dS S Si i
M
i
N
= −
( ) ( ) (3)
It is important to point out that the sampling proper-
ties of the entropy measure as defined here will depend
on the degree of the node. To see this, consider a node of
degree 10, with half of the neighbors having pij = 1/5
while the other half have pij = 0. Then, the entropy is S =
log 5/log 10 ≈ 0.70. Consider now another node of degree
100, again with half of the neighbors having pij = 1/50
and the rest pij = 0. In this case, the entropy is S = log
50/log 100 ≈ 0.85. Thus, while the two nodes have, mod-
ulo the degree, the same stochastic flux distribution, the
entropies are widely different with the higher connected
node exhibiting much higher entropy. A consequence
of this is that the sampling properties and in particular
the expected variance of the entropy will decrease with
increasing degree. This means therefore that when com-
paring entropy measures between the two phenotypes,
the comparison must be done on a degree-by-degree
basis. In particular, the paired Wilcoxon (non-
parametric) test used above to evaluate differences in the
global entropy distributions performs the comparison on
a node by node basis and therefore circumvents the
degree-dependence problem posed by the entropy
measure.
Feature selection based on local differential entropy
It is clear however that ranking nodes according to the
magnitude of entropy change may skew selection to
nodes of small degree as high degree nodes are less likely
to show big entropy changes. To address this difficulty
we adopt an empirical approach to derive a null distribu-
tion of expected entropy changes as a function of the
degree of the node. Specifically, the approach we used is:
1. Randomise the gene expression profiles of each
sample, reconstruct stochastic flux matrices for the
two phenotypes and calculate differential entropy
values.
2. For nodes with the same degree, estimate sam-
pling variance. Generally, for nodes of higher degree
(i.e ki > 50), there were too few nodes to estimate
sampling variance, so high-degree nodes were pooled
together and a single variance estimate obtained for
each pool. In particular, nodes with degrees in the
following ranges were pooled in corresponding bins:
(50, 75), (75, 100), (100, 150), (150, max ki). This
procedure was justified as we observed that the sam-
pling variance was fairly constant for high-degree
nodes.
3. Repeat steps 1 & 2 a total of 100 times to obtain
100 variance estimates for each degree or pooled
degree.
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4. Obtain smoothed standard error estimates by
averaging the standard errors over the 100
randomisations.
5. We observed that the resulting standard deviation,
s, was a decreasing monotonic function of the
degree of the node. In particular, it took the power-
law form
( ) /k a kb= (4)
6. Estimate the parameters a and b using non-linear
least squares [29].
7. For node i of degree ki and observed differential
entropy value dSi we computed a P-value by com-
paring dSi to the value expected under the null
given by a Gaussian of mean 0 and standard devia-
tion s (ki) with the parameters as estimated in the
previous step.
8. Finally, nodes are ranked according to the signifi-
cance of the P-values, and subsequent FDR estima-
tion is applied [30].
Average local correlation
We compare our local entropy metric to an alternative
metric that quantifies the strength of the local positive
flux distribution. Specifically, given a node i we can esti-
mate the strength of the positive information flux sur-
rounding node i by simply averaging the correlations
over the nearest neighbors
C
k
Ci
i
ij
j N i
=
∈
∑1
( )
(5)
Since this is done for each cancer phenotype sepa-
rately, we obtain for each node the difference in the
mean local correlation as
dC C Ci i
M
i
N
= −
( ) ( ) (6)
In addition, we also consider the average of local abso-
lute correlations, that is,
| | | |
( )
C
k
Ci
i
ij
j N i
=
∈
∑1 (7)
and similarly, the difference in mean local absolute
correlation,
d C C Ci i
M
i
N| | | | | |( ) ( )= − (8)
However, since generally we would expect larger local
entropies to reflect decreases in the positive information
flux or to reflect lower absolute correlations (i.e less
order), we redefine these metrics as
H
k
C
D
k
C
i
i
ij
j N i
i
i
ij
j N i
= −
= −
∈
∈
∑
∑
1
1
1
1
| |
( )
( )
and use these metrics in the comparisons to entropy. In
comparing all the metrics between the two phenotypes,
the P-values obtained from the paired Wilcoxon rank sum
tests are directly comparable, since the same number of
values are being compared for each choice of metric.
Results
Using entropy to characterise the metastatic cancer
phenotype
Based on the observation that more aggressive meta-
static breast cancer is associated with a higher genomic
instability (i.e a higher frequency of genomic alterations)
[21,22,24,31], we sought to investigate if this could be
reflected in integrated PIN-mRNA expression networks.
Specifically, we hypothesized that genomic (and epige-
nomic) alterations would lead to disruptions in the
dynamics of information flow on protein interaction
networks, and that this disruption would manifest itself
as a higher degree of randomness in the patterns of
local gene expression correlations.
While gene expression data represents a steady state,
we posited that information flux in the network and
under a certain condition is driven by positive correla-
tions in gene expression between the interacting proteins.
We thus assigned to each edge in the PIN a positive “flux
weight”, the magnitude of which reflects the strength of
the Pearson correlation between the corresponding
expression profiles (Methods). The weights were normal-
ised further to yield a stochastic matrix pij (∑jÎN(i) pij = 1
for all i Î N, Methods), describing the relative strengths
of the local Pearson correlations. Thus, pij can be inter-
preted as the probability of signal transmission from pro-
tein i to a neighbor j relative to all other interacting
neighbors of protein i. Using this stochastic matrix we
propose to use an entropy-like measure that quantifies
the amount of disorder or randomness in the local flux
distribution (Methods). Specifically, for each node i we
compute an entropy of flux distribution, Si, as
S
k
p pi
i
ij
j N i
ij= −
∈
∑1log log
( )
(9)
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Thus, nodes with significant changes in S between two
phenotypes represent points in the gene network where
the degree of randomness in the information flow
changes.
There are in principle other measures one could use
to quantify the disruption in information flow in a net-
work. One possibility is to consider for each node i the
distribution of Pearson correlation values Cij with each
of its neighbors [11]. By comparing the distribution of
correlation values C C j N ii
M
ij
M( ) ( ){ ( )}:= ∈ in metastic
breast cancer with the corresponding distribution in
non-metastatic cancer Ci
N( ) one can thus identify nodes
for which the local flux distribution changes. These
nodes may therefore represent genes that are disrupted
in the more aggressive phenotype. However, we argued
that the degree of randomness in the local flux distribu-
tion maybe a better characteristic of a metastatic net-
work than any statistic based on the difference in
correlation values (Figure 1). Indeed, as the hypothetical
example in Figure 1 shows, the metastasis phenotype
may be associated with a significant increase in random-
ness but not necessarily with a significant change in the
average nearest-neighbor correlation. On the other
hand, there could be nodes with a significant change in
the mean nearest neigbour correlation but without a
change in local randomness. We therefore sought to
determine if randomness could be a better intrinsic
characteristic of the metastatic phenotype than
Figure 1 Local entropy changes in integrated PIN-mRNA networks. In the above hypothetical networks, an edge represents a documented
interaction between the corresponding proteins in the PIN. The color of the edge codes for the pairwise correlation in mRNA expression in two
different conditions, here non-metastatic and metastatic cancer. In this hypothetical example, gene-1 is positively correlated with maximal value
(C = 1) to the first 6 genes, but negatively correlated (C = -1) to the remaining four in the non-metastatic PIN-mRNA network. These values
translate to a stochastic positive flux vector p = 1/6 (1, 1, 1, 1, 1, 1, 0, 0, 0, 0) and to an entropy value of 0.78 (Methods). In this hypothetical
example, gene-1 is lost/mutated in metastatic cancer, leading to a loss of mRNA expression correlation and anti-correlation with the nearest
neighbors. This introduces more disorder/randomness in the local flux distribution, illustrated here by zero correlation values. The resulting local
entropy takes on a maximum value of 1, and so for this node there is a large increase in the local entropy which is statistically significant. In
contrast, a Wilcoxon rank sum test between the correlation values C = (1, 1, 1, 1, 1, 1, -1, -1, -1, -1) and C = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0) yields a non-
significant P-value of 0.2.
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orthogonal measures such as local mean correlation or
absolute correlation which do not necessarily quantify
such randomness.
Increased entropy in metastatic breast cancer
To test our hypotheses we first integrated a highly
curated network of protein interactions (from the
Human Protein Reference Database) [2] with a high-
quality cancer gene expression data set from 286
breast cancer patients [23], of which 107 relapsed
(Methods). There were 7279 protein coding genes with
expression profiles and with representation in the
HPRD PIN. Of these, 167 were isolated nodes, which
were therefore removed from the analysis, leaving n =
7112 nodes. The PIN is sparse containing a total of
only 31678 edges, representing 0.01% of the maximum
possible number of edges. The degree distribution
exhibited long-tails with the highest degree node hav-
ing 222 neighbors. About 60% of nodes had a degree
less or equal than 5, while ~75% of nodes had a degree
less than 10. To ensure comparibility of correlation
values, we sampled 107 samples at random from the
179 non-metastatic samples, to build the correspond-
ing non-metastatic PIN-mRNA network. The meta-
static PIN-mRNA network was constructed using all
107 metastatic samples.
We first restricted the analysis to the 1903 nodes of
degree ≥ 10, representing about 25% of all nodes in the
network, and compared the entropy measures between
the metastatic and non-metastatic networks. First, we
found that the local entropies of both metastatic and
non-metastatic networks were significantly lower than
that of a null network obtained by randomising the
expression profile of each tumour sample (Figure 2A).
This is in line with the expectation that local correlation
patterns are far from random. We also observed that
our proposed entropy measure was discriminatory of
the two cancer phenotypes, with a small yet significant
increase in entropy in the metastatic network (Wilcoxon
paired test P = 2 × 10-16). To test the robustness of
these results we compared the metastatic network to
other non-metastatic PIN-mRNA networks obtained by
randomly selecting a different set ("bootstraps”) of 107
non-metastatic tumours. Viewing these as perturbations
of the original non-metastatic network, we performed a
total of 10 bootstraps and in all cases the entropy of the
metastatic network was higher (Figure 2B, Wilcoxon
paired test P < 0.005 in all cases). We also observed that
differential entropy values were highly correlated
between the different bootstraps (mean Pearson correla-
tion 0.77), thus allowing values to be averaged.
Differences in local entropy between the metastatic
and non-metastatic network were not substantial in
absolute terms, however, the paired test results clearly
showed statistical significance and a trend towards
increased entropy. To obtain a handle on the statistical
significance of individual entropy changes, we first
noted that the variance in differential entropy values
was dependent on the degree of the node (Additional
file 1A), which was not unexpected (Methods). Specifi-
cally, high degree nodes are generally less likely to exhi-
bit large entropy changes. To overcome this problem we
derived degree-dependent variance estimates of the dif-
ferential entropy, which allowed specific P-values to be
derived (Methods). We observed that the variance
decreased with the degree of the node in the form of a
power-law allowing P-values to be estimated for nodes
of any degree (Figure 2C). Confirming the paired test
analysis, individual P-values exhibited a clear skew
towards 0 suggesting many significant changes (Figure
2D). Among the top 200 ranked nodes (stringent FDR <
0.001) (Additional file 2), 133 showed entropy increases
(Binomial test P < 10-6). Using the P-values to rank
the genes also confirmed that the selected nodes were
now not skewed towards those of low-degree (Addi-
tional file 1B).
Because these results were obtained on the selected
nodes of high degree (ki ≥ 10), we asked if this result
would remain significant had we included all nodes. We
thus repeated the analysis using all 5592 nodes with at
least two neighbors (entropy undefined for ki < 2). This
showed that entropy was also significantly higher in meta-
static breast cancer (Wilcoxon paired test P < 10-100),
despite the fact that non-hubs made up 75% of the net-
work. Thus, while nodes of lower degree generally also
showed increases in entropy we focused our analysis on
the higher-degree nodes (ki ≥ 10) as these are more prone
to disruption in cancer [6,7].
Validation in other breast cancer cohorts
We next asked if the increase in local entropy found in
the EMC data set is a robust finding independent of the
expression data set used. We thus collected three addi-
tional breast cancer expression data sets that had been
profiled with Affymetrix arrays [24-26]. For all three
data sets we constructed the corresponding PIN-mRNA
networks in both metastatic and non-metastatic disease
using the same procedure as for the EMC data. The
PIN-mRNA networks were of similar size to the one
obtained from the EMC data set. Remarkably, as with
the EMC PIN-mRNA networks, we observed that the
local entropies (of nodes with degree ki ≥ 10) were sig-
nificantly increased in the metastatic networks (Figure
3A). In all cases, we verified that the increase in entropy
was robust to the choice of non-metastatic network. We
emphasize here again that metastatic and non-metastatic
PIN-mRNA networks were derived using the same
number of samples, thus excluding the possibility that
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the increase in entropy is a sample-size effect. However,
the increase in entropy was less marked when the analy-
sis was extended to include all nodes of degree ≥ 2
(Mainz P = 4 × 10-7, Frid P > 0.5, LoiUnt P = 2 × 10-5).
It is natural to ask if the increase in entropy seen
across all cohorts is due to the same genes or instead if
in each cohort the subset of genes exhibiting increases
is different. To address this we selected the 133 genes
which showed the most significant increases in entropy
in the EMC data set (out of the top 200 genes with
most significant changes (FDR < 0.001), 133 showed
increases) and verified that these generally also showed
more significant increases in entropy in the validation
sets (Figure 3B). This supports the view that there is
gene-wise consistency in the metastasis-associated
entropy increases seen across all four cohorts.
Figure 2 Local entropy is increased in metastatic breast cancer. A) Comparison of local entropies for the 1903 proteins with degrees ≥ 10
between the non-metastatic, metastatic and random weighted networks. The entropies in the metastatic network exhibit significantly higher
values than those in the non-metastatic network: P-value given is from a one-tailed paired Wilcoxon rank sum test. Both non-metastatic and
metastatic networks show significantly lower entropies than those of a purely random network obtained by randomisation of expression profiles.
B) Differential entropy values (metastatic minus non-metastatic) are significantly greater than zero for 10 different choices of non-metastatic
networks obtained by bootstrapping samples. One-tailed paired Wilcoxon rank sum test P-values are given. C) The expected variation in differential
entropy under the null distribution against node degree. The green-line is a non-linear least squares fit of a power-law function of the form a/kb
where k is the node degree. Estimated parameter values are â = 0.0086; b
^ = 0.08411. D) Histogram of P-values of genes (nodes). P-values were
estimated by comparing observed differential entropy values to those expected under the null using the variance estimates from C).
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Figure 3 Increased entropy in metastatic breast cancer is independent of breast cancer cohort. A) Comparison of local entropies for the
proteins with degrees ≥ 10 between the non-metastatic, metastatic and random weighted networks in the three validation cohorts: Mainz (1900
genes), Frid (1270 genes) and LoiUnt (1899 genes). The entropies in the metastatic network exhibit significantly higher values than those in the
non-metastatic network: P-value given is from a one-tailed paired Wilcoxon rank sum test. Both non-metastatic and metastatic networks show
significantly lower entropies than those of a purely random network obtained by randomisation of expression profiles. B) The top 200 genes
with most significant P-values (FDR < 0.001) as identified in the EMC (discovery) data set are grouped according to increases in entropy (1) or
decreases (-1). The numbers of genes within each group and represented in the validation set are given just above x-axis. The y-axis labels the
statistics (dSi/si) of these genes in the corresponding validation set, and the boxplot allows a direct comparison to be made. The P-value is from
a one-tailed Wilcox rank sum test as the alternative hypothesis is that the statistics should be larger for those genes identified to undergo
increases in entropy in the discovery set.
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Randomness as an intrinsic property of the metastatic
phenotype
Given the robust finding of increased entropy in meta-
static breast cancer, we next asked if other local mea-
sures could discriminate between the two cancer
phenotypes. Specifically, we compared entropy against
the average local correlation, that is, the mean correla-
tion of a node with its nearest neighbors, as well as the
mean local absolute correlation (Methods).
We expected that the mean correlation (or absolute
correlation) in expression would decrease in metastatic
breast cancer as a result of the increased frequency in
genomic/epigenomic alterations. We confirmed this
across all four data sets using the same one-tailed paired
Wilcoxon test (Table 1). Comparison of the P-values
obtained using entropy and average correlation measures
however also showed that entropy was substantially more
different between metastatic and non-metastatic breast
cancer (Table 1).
As an alternative test we also asked how many nodes
exhibited an increase or decrease in entropy, average
correlation or absolute correlation and tested the
strength of any deviation from the null using the bino-
mial test. By performing this binomial test we are also
comparing entropy to a paired t-test of correlation
values as the directionality of change is determined by
the difference in mean correlations. We observed that
there were a substantially larger number of nodes exhi-
biting increased entropy in metastatic breast cancer
than nodes exhibiting lower average correlation (Figure
4A). In line with this, binomial test P-values of skewness
derived from differential entropy values were also sub-
stantially more significant than those derived from dif-
ferences in mean local correlation (Figure 4B).
Interestingly, comparing differential entropy to changes
in the local mean absolute correlation, we observed that
the absolute correlation was a good surrogate for
entropy. However, entropy did generally show more
significant changes than the absolute correlation (Table
1, Figure 4). Thus, these results demonstrate that
increased entropy in the local patterns of gene expres-
sion correlations may be a more intrinsic property of
the metastatic phenotype and thus constitute a more
useful measure for identifying gene subnetworks impli-
cated in breast cancer metastasis than subnetworks
derived from direct correlation measures.
Biological significance
We would expect that nodes exhibiting the most signifi-
cant increases in entropy may point to genes and signal-
ling pathways that are more frequently altered in the
metastatic or poor prognosis breast cancer phenotype,
irrespective of the modality of the underlying alteration.
Of the 133 genes showing the most significant increases
in entropy (Additional file 2) several have expression
levels that have already been associated with a poor
prognosis and distant metastasis in breast cancer (e.g
CDC2, CCNB1, MYBL2, MAD2L1) and which have
functions related to the cell-cycle and DNA replication
[32,33]. Graphical depiction of the nearest neighbor
sub-network surrounding e.g MYBL2 confirmed the
increase in entropy in the metastatic phenotype (Figure
5). For instance, one can observe how a strong inhibi-
tory interaction with CCND1 and strong correlations
with CCNE1 and RBL1 become disrupted in the meta-
static phenotype. It is clear that nearest neighbors of
MYBL2 (e.g CCNA2) also undergo increases in entropy,
thus implicating larger gene modules, in this case a cell-
cycle module, that are altered in metastatic disease.
Interestingly, GSEA (Gene Set Enrichment Analysis
using a Fisher-test) of genes with increased entropy in
the metastatic phenotype revealed enrichment of several
biological pathways, notably apoptosis, natural killer cell
mediated cytotoxicity and interleukin-2 (IL2), androgen
receptor and insulin growth factor (IGF) signalling
(Table 2). Corresponding subnetworks for IL2RB,
IGFBP7 and BCL2 clearly confirmed the increase in
entropy associated with these genes and pathways (Fig-
ure 5).
Since GSEA was performed on the top 200 genes
using the 1903 gene list as the background reference,
the enrichment of any biological pathways and in parti-
cular those of apoptosis and IL2/IGF is very significant
and not caused by the selection of nodes of high degree.
As a control and to confirm this further, we observed
no enrichment of any biological pathway among the
genes showing decreases in entropy (Table 2). Although
this could be explained in part by the smaller number of
genes showing decreases (67 vs 133), we only obtained
significance of one biological term (regulation of transla-
tion initiation) when we expanded the 67 gene set to the
133 with the most significant entropy decreases.
Table 1 One tailed paired Wilcoxon test P-values
comparing distribution of local measures of disruption
in information flow in metastatic and non-metastatic
PIN-mRNA networks across four different breast cancer
cohorts
Metric EMC (n =
1903)
Mainz (n =
1900)
Frid (n =
1270)
LoiUnt (n =
1899)
dC 0.001 0.01 0.54 2e-13
d C 1e-16 5e-10 1e-12 3e-70
dS 2e-16 6e-13 <1e-100 <1e-100
dC denotes the difference in mean local correlation, d C denotes the
difference in mean local absolute correlation and dS denotes the differential
local entropy. In the case of the non-metastatic networks, values were
averaged over 10 distinct bootstraps before computation of the P-values. The
number of pairs (nodes) in the test, n, corresponding to the number of nodes
in the network with degree ≥ 10 are given.
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It is likely that the increases in entropy associated with
specific genes are caused by a higher frequency of
underlying mutations, losses or epigenetic silencing.
Using copy-number and sequencing data of a large
cohort of 171 breast tumours (38 metastasized, 130 no-
metastasis) [31] we observed an increased frequency of
losses in those tumours that metastasized for many of
the top ranked genes including BCL2 (18% vs 13%),
IGFBP7 (11% vs 6%), IGF1 (8% vs 2%) (Additional file
3). Similarly, TP53 was mutated in 31% of tumours that
metastasized against 17% in those tumours that did not.
Of the top 133 genes exhibiting increases in entropy, 90
could be mapped to the array CGH study and of these,
68 (75%) showed more frequent losses in primary
tumours that metastasized (Additional file 4). In con-
trast, 65% of genes exhibiting no significant changes in
entropy were more frequently lost in metastatic cases
(Additional file 4). Thus, genes with significant increases
in entropy were approximately 1.6 times more likely to
undergo more frequent losses in disseminating tumours
(Fisher test P = 0.08).
Discussion
In this work we have explored a specific statistical prop-
erty of integrated protein interaction and cancer mRNA
expression networks. Our hypothesis was that the meta-
static cancer phenotype is characterised by a higher
level of randomness in the sense of a more disordered
local gene expression correlation pattern. In other
words, since one may view the protein interactions as
imposing to some degree constraints on the allowed
local gene expression patterns [9,11], we posited that
these constraints would be violated to a higher extent in
breast tumours which exhibit a more invasive pheno-
type. To test this we introduced a stochastic matrix on
the PIN, modeling positive information fluxes around
any given node, and from it we defined a local entropy
measure which quantifies the degree of randomness of
Figure 4 Local entropy better characterises the metastatic network. A) For each of the four breast cancer cohorts, we count the number of
genes showing increases (grey) and decreases (black) in local entropy (S), negative local mean correlation (D), and heterogeneity (negative local
mean absolute correlation) H in the metastatic PIN-mRNA networks. In all cases, nodes of degree ≥ 10 were selected. B) Corresponding -log10(p-
values) from a one-tailed binomial test. The line -log10(0.05) is shown in green.
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Figure 5 Biological subnetworks exhibiting significant increases in entropy. We contrast the integrated PIN-mRNA metastatic and non-
metastatic networks for four nodes/genes exhibiting significant increases in entropy and related to tumour suppressor pathways and cancer
hallmarks: MYBL2 and cell-cycle, IGFBP7 and IGF-signalling, IL2RB and IL2 immune-mediated tumour suppression, BCL2 and apoptosis. In each
case, we only depict the nearest neighbors (interacting protein partners) of the selected nodes. The edge color shows the strength of the
Pearson correlation C in expression between the two genes across the given phenotype: bright red (0.5 <C < 1), dark red (0.25 <C < 0.5), grey
(-0.25 <C < 0.25), dark green (-0.5 <C < -0.25), bright green (-1 <C < -0.5).
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this flux distribution. Using this entropy measure we
could show that the metastatic phenotype is indeed
characterised by a higher level of entropy independently
of the breast cancer cohort considered. While entropy
changes were not large in absolute terms due to the
focus on nodes of relatively high degree (degree ≥ 10),
we were able to show using an empirically derived
degree dependent variance estimator, that the changes
in entropy were significant with a clear skew towards
higher entropy in the metastatic phenotype. Moreover,
we were able to show that genes exhibiting significant
increases in local entropy in one data set, did so also in
the independent cohorts, supporting the view that the
disruptions in local expression patterns that we have
found are biologically genuine and of relevance to the
metastatic phenotype. It is interesting though that the
increase in entropy was less marked when analysis was
extended to all nodes of degree larger than 1, indicating
that low-degree nodes showed less consistent directional
changes, in line with the expectation that low-degree
nodes may be functionally less important.
We also observed significant enrichment of relevant
biological pathways, specially those with tumour suppres-
sor functions, among genes showing increases in entropy
in the metastatic phenotype, but not so for genes show-
ing decreases in entropy. This supports the view that it is
increases in randomness that may be of most functional
consequence. A higher randomness in the co-expression
patterns of genes important to the apoptotic cascade may
indicate that this pathway is less functional in primary
tumours that eventually metastasize. Similarly, our find-
ings suggest that increased randomness in the patterns of
expression of the IL2 pathway, a well-known tumour
suppressor pathway mediating tumour inhibition through
formation of natural killer cells [34], is a critical determi-
nant of breast cancer metastasis. This confirms other
reports that immune-response pathways are important in
prognosis prediction of breast cancer [35,36]. While the
IGF-pathway has been implicated as a mediator of breast
cancer progression and is also involved in the regulation
of apoptosis [37-39], our results suggest a novel impor-
tant role for IGFBP7 and IGF-signalling.
Generally, there were other instances where the identi-
fied genes formed interlinked subnetworks implicating
whole gene modules that show increased entropy. It will
therefore be interesting to extend our analysis to metrics
that quantify the degree of randomness across whole
subnetworks as opposed to single nodes. Among the lar-
ger modules, we identified one associated with the cell-
cycle (CDC2, CDC20, MYBL2, MAD2L1) consistent
with many other studies showing the importance of cell-
cycle genes in breast cancer prognosis [32,33]. Of note,
we also found local entropy increases in subnetworks
surrounding genes involved in invasion (SPARC, MMP1,
MMP2, MMP3). SPARC expression itself has been asso-
ciated with clinical outcome in breast cancer in a large
number of studies, for example see [40,41]. In this
regard, it is worth pointing out that we have rediscov-
ered these important cell-cycle and extracellular matrix
modules without directly comparing expression levels
between metastatic and non-metastatic breast cancer,
but rather by using entropy to compare the randomness
of expression patterns within each phenotype. Thus, our
proposed entropy metric is able to identify biological
mechanisms related to the cancer hallmarks and a poor
prognosis phenotype.
Perhaps most remarkably is the fact that entropy outper-
formed other local measures of information flux, in the
sense that entropy better characterized the metastatic phe-
notype. One competing measure we considered was the
average nearest-neighbor correlation in gene expression,
which clearly was less effective in distinguishing the two
cancer phenotypes. Similarly, entropy characterised the
metastatic phenotype more closely than the effect size sta-
tistic provided by a t-test. The t-test is similar to the
method used in [11] to identify features disrupted in poor
prognosis breast cancer. In that study, the authors identi-
fied BRCA1 as one of the top genes exhibiting changes in
the mean local correlation. In terms of differential entropy
however, BRCA1 was not highly ranked because differen-
tial entropy only measures the change in the degree of
randomness of the local correlation distribution, while as
shown in [11]BRCA1 exhibits a fairly uniform switch from
positive to negative correlations with its interacting part-
ners, a switch which is therefore not necessarily associated
with an increase in disorder or randomness. This example
highlights the fact that although differential entropy can
miss important genes, that it constitutes a metric that is
complementary to the one used in [11]. Therefore, it will
be interesting to compare the alternative metrics in rela-
tion to the ranking of nodes. However, the result obtained
here that increased entropy is a better distinguishing fea-
ture of the metastatic phenotype supports the view that
Table 2 Gene Set Enrichment Analysis of the top 200
genes of which 133 showed increases in entropy
Pathway P (dS > 0) P(dS < 0) Example genes
Apoptosis 6e-7 n.s FAS, TP53, TP53BP2, BCL2, BCL2L1,
CASP3
IL2 6e-4 n.s IL2RB, HRAS, FOS, SOS1, LCH, SHC1
AR 8e-4 n.s SNX1, RBX1, BSG, NOTCH1, RAB27A,
TAF9
IGF1 9e-4 n.s IGF1, IRS1, IGFBP7
While we observed enrichment of biological pathways among genes showing
increases in entropy, there was none among the 67 genes showing decreases.
P-values of enrichment (one tailed Fisher’s exact test) against genes showing
entropy increases (dS > 0) and decreases are given (dS < 0) and were
calculated using all nodes of degree ≥ 10 as reference (1903 genes) to avoid
intrinsic literature bias. n.s = not significant
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changes in the randomness of the local correlation pat-
terns may be more relevant than changes in mean correla-
tion levels. To confirm this further, we took the mean of
the absolute correlations as another metric and compared
it to entropy. In line with the expectation that increases in
entropy are generally caused by drops in absolute correla-
tion values, we observed that changes in the mean abso-
lute correlation, while not outperforming entropy, was a
good surrogate for it. It will therefore also be interesting
to compare our entropy metric to other network metrics
that quantify randomness or to metrics that combine ran-
domness and changes in mean correlation levels.
The observed increase in entropy in the metastatic
breast cancer networks may have a clear biological
interpretation, as genomic and epigenomic alterations
are more frequent in primary tumours that metastasize
[21,24,31]. This increased frequency of alterations is
true for losses, mutations and amplifications (high-level
gains) but does not necessarily hold for low-level gains
[24,31]. It was therefore encouraging to observe that
genes undergoing the most significant increases in
entropy were also more likely to undergo more frequent
losses in the tumours that metastasized. Although this
association was only marginal, this could be because the
genomic alteration data came from a different cohort.
Another potential difficulty in linking entropy changes
to gene alterations is that a substantial number of altera-
tions are not copy-number changes but instead may
represent point mutations, rearrangements, or epigenetic
aberrations, and large scale profiling of these types of
alterations is still ongoing. Thus, the question if differ-
ential entropy selects for genes that are more frequently
altered and how the directionality of change might relate
to the type of alteration is still an open question that we
hope to address in future studies. An easier context in
which to study this would be to compare integrated
PIN-mRNA networks for cancer and corresponding nor-
mal tissue, as normal tissue exhibits significantly much
lower levels of alterations. However, this also requires
relatively large normal and cancer tissue data sets pro-
filed on the same platform and ideally as part of the
same study. While in breast cancer such data sets are
only now becoming available, it will be interesting in the
meantime to pursue this question in other cancers.
Conclusions
Metastatic breast cancer is characterised by an increase
in the randomness of the local expression correlation
patterns. The entropy metric proposed here may there-
fore be a useful tool for identifying genes and signalling
pathways implicated in the metastatic process of other
cancers. We foresee that further network-theoretical
studies of integrated PIN-mRNA expression networks in
the context of cancer genomics will be fruitful.
Additional material
Additional file 1: Differential entropy and node degree. A)
Differential entropy change is plotted against node degree. One
observes a skew in the sense that high degree nodes exhibit smaller
changes in entropy. This is a theoretical consequence of the entropy
defintion. Thus using to rank genes is biased to nodes of low degree. B)
The negatiive of the log(P-values) of differential entropies against node
degree. Evaluating the statistical significance of the entropy changes we
now observe that for every degree there are significant changes in
entropy, thus removing the skew. Green line is line defined by P = 0.05.
Additional file 2: Genes ranked according to differential entropy. All
nodes of degree ≥ 10 are ranked according to significance of difierential
entropy changes between metastatic and non-metastatic breast cancer
(EMC data set). Columns label common gene symbol, the difference in
entropy (metastatic minus non-metastatic, averaged over the 10
bootstraps), the degree of the node in the PIN, the estimated P-value
and false discovery rate (FDR).
Additional file 3: Relation of differential entropy to patterns of
differential loss and gain in breast tumours. For the top 200 genes
showing the most significant entropy changes, we provide the
frequencies of genomic copy-number gain and loss across 171 breast
tumours [31], stratified according to whether primary tumours
metastasized (DM) or not (NoDM). The differential gains and losses are
also provided in table. NA indicates that that gene had no oligo
representation on the array.
Additional file 4: Increased entropy and genomic loss. Of the top
200 nodes with most signficant entropy changes, 133 showed significant
increases in the metastatic phenotype, and 90 of these genes could be
mapped to an oligo array comparative genomic hybridisation study over
171 breast tumours [31]. Left panel plots the difference in the frequency
of loss of the gene between the tumours that metastasized and those
that did not (y-axis) against the negative logarithm of the P-value for the
differential entropy (x-axis). Right panel shows the same plot for the 133
genes showing least significant changes in entropy. Genes with
significant increases in entropy were 1.6 times more likely to be more
frequently lost in poor prognosis tumours (Fisher test P = 0.08).
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